Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Revenue (2019 - 2026)

Updated

Aligos Therapeutics (ALGS) posted Revenue of $2.83 million for Q3 2026, up 281.9% from $741,000 a year earlier.

Analysis

Aligos Therapeutics (ALGS) Revenue (2019 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Revenue at Aligos Therapeutics was $5.83 million, up 122.2% year-over-year; for FY2025, it was $2.19 million, down 39.5% from FY2024.

  • Annual Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • In prior years, Aligos Therapeutics' Revenue was $3.61 million in FY2024 (-61.3%), $9.34 million in FY2023 (-32.9%), $13.91 million in FY2022 (+219.0%) and $4.36 million in FY2021 (+218.6%).
  • Quarterly Revenue has run from a low of $169,000 in Q4 2025 to a high of $4.29 million in Q2 2023 over five years.
  • On a year-over-year basis, Revenue increased in two of the last seven quarters, with growth averaging 120.7%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q4 2022, with growth of 863.8%; the weakest was Q2 2024, with a decline of 75.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 25.40 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 17.40 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 8.30 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 16.58 Bn
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - 2.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.83 Mn
Mar 31, 2026 2.83 Mn
Dec 31, 2025 169,000.00
Sep 30, 2025 741,000.00
Jun 30, 2025 965,000.00
Mar 31, 2025 311,000.00
Dec 31, 2024 606,000.00
Sep 30, 2024 1.25 Mn
Jun 30, 2024 1.06 Mn
Mar 31, 2024 694,000.00
Dec 31, 2023 2.01 Mn
Sep 30, 2023 2.15 Mn
Jun 30, 2023 4.29 Mn
Mar 31, 2023 2.58 Mn
Dec 31, 2022 3.54 Mn
Sep 30, 2022 4.11 Mn
Jun 30, 2022 3.69 Mn
Mar 31, 2022 2.57 Mn
Dec 31, 2021 367,000.00
Sep 30, 2021 1.54 Mn
API Access

Aligos Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ALGS&period=max&api_key=YOUR_API_KEY